Practice Economics

CMS delays Stage 3 meaningful use until 2018, simplifies program


 

References

Given the changes that will come as a result of MACRA, CMS is taking comments on the final rule to help inform future policy on how it and MACRA will align.

gtwachtman@frontlinemedcom.com

Pages

Recommended Reading

Uninsured dropped by nearly 9 million between 2013 and 2014
MDedge Hematology and Oncology
The ‘financial toxicity’ of multiple myeloma
MDedge Hematology and Oncology
Pioneer ACOs cut out low-value care
MDedge Hematology and Oncology
Poll finds overwhelming support for Medicare coverage of end-of-life talks
MDedge Hematology and Oncology
Hospital care unaffected by quality payments, GAO finds
MDedge Hematology and Oncology
Hospital care unaffected by quality payments, GAO finds
MDedge Hematology and Oncology
GAO: Physicians, hospitals struggle to achieve EHR interoperability
MDedge Hematology and Oncology
California governor signs physician-assisted suicide bill into law
MDedge Hematology and Oncology
Telemedicine poses novel legal risks for doctors
MDedge Hematology and Oncology
Multistate compact could ease telemedicine licensing woes
MDedge Hematology and Oncology

Related Articles